OREX を保有するビリオネア

ビリオネア ポートフォリオ内保有比率 保有株数(百万株) % 平均取得コスト 平均取得コスト リターン

ファンダメンタルズ

  • N/A
    株価収益率(PER)

  • 0.0
    利回り(%)

  • 123百万ドル
    発行済み株式数

  • 7193M
    時価総額

News & Insights

ABOUT

OREX

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its product candidates include NB32, which has completed Phase III clinical trials and is being studied in a cardiovascular outcomes trial; and E...

Soros, Druckenmiller among hedgies profiting in market plunge

NEWS

U.S. stocks bounce after 2-day Brexit-induced rout

READ MORE